 BOSTON, Nov. 07, 2022 GLOBE NEWSWIRE -- Tango Therapeutics, Inc. NASDAQ: TNGX, a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that Barbara Weber, M.D., President and Chief Executive Officer of Tango Therapeutics, is scheduled to participate in the following upcoming investor conferences in November. 